Literature DB >> 16185882

Modeling of farnesyltransferase inhibition by some thiol and non-thiol peptidomimetic inhibitors using genetic neural networks and RDF approaches.

Maykel Pérez González1, Julio Caballero, Alain Tundidor-Camba, Aliuska Morales Helguera, Michael Fernández.   

Abstract

Inhibition of farnesyltransferase (FT) enzyme by a set of 78 thiol and non-thiol peptidomimetic inhibitors was successfully modeled by a genetic neural network (GNN) approach, using radial distribution function descriptors. A linear model was unable to successfully fit the whole data set; however, the optimum Bayesian regularized neural network model described about 87% inhibitory activity variance with a relevant predictive power measured by q2 values of leave-one-out and leave-group-out cross-validations of about 0.7. According to their activity levels, thiol and non-thiol inhibitors were well-distributed in a topological map, built with the inputs of the optimum non-linear predictor. Furthermore, descriptors in the GNN model suggested the occurrence of a strong dependence of FT inhibition on the molecular shape and size rather than on electronegativity or polarizability characteristics of the studied compounds.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185882     DOI: 10.1016/j.bmc.2005.08.009

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

Review 1.  Genetic algorithm optimization in drug design QSAR: Bayesian-regularized genetic neural networks (BRGNN) and genetic algorithm-optimized support vectors machines (GA-SVM).

Authors:  Michael Fernandez; Julio Caballero; Leyden Fernandez; Akinori Sarai
Journal:  Mol Divers       Date:  2010-03-20       Impact factor: 2.943

2.  Computational neural network analysis of the affinity of N-n-alkylnicotinium salts for the alpha4beta2* nicotinic acetylcholine receptor.

Authors:  Fang Zheng; Guangrong Zheng; A Gabriela Deaciuc; Chang-Guo Zhan; Linda P Dwoskin; Peter A Crooks
Journal:  J Enzyme Inhib Med Chem       Date:  2009-02       Impact factor: 5.051

Review 3.  Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction.

Authors:  Haiyan Li; Jin Sun; Xiaowen Fan; Xiaofan Sui; Lan Zhang; Yongjun Wang; Zhonggui He
Journal:  J Comput Aided Mol Des       Date:  2008-06-24       Impact factor: 3.686

4.  Imidazole-containing farnesyltransferase inhibitors: 3D quantitative structure-activity relationships and molecular docking.

Authors:  Aihua Xie; Srinivas Odde; Sivaprakasam Prasanna; Robert J Doerksen
Journal:  J Comput Aided Mol Des       Date:  2009-05-29       Impact factor: 3.686

5.  Molecular Descriptors in Modelling the Tumour Necrosis Factor-α Converting Enzyme Inhibition Activity of Novel Tartrate-Based Analogues.

Authors:  P Singh
Journal:  Indian J Pharm Sci       Date:  2013-01       Impact factor: 0.975

6.  2D-QSAR study of some 2,5-diaminobenzophenone farnesyltransferase inhibitors by different chemometric methods.

Authors:  Saeed Ghanbarzadeh; Saeed Ghasemi; Ali Shayanfar; Heshmatollah Ebrahimi-Najafabadi
Journal:  EXCLI J       Date:  2015-03-30       Impact factor: 4.068

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.